Monitor for additional insider selling or commentary around earnings; current activity is minimal and likely routine, but absence of buying may reflect neutral sentiment.
LH drugs
LH drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Feb 24 $286.41entry
- T+1 · 9mo ago −1.51%α −2.35% · $282.07
- T+5 · 9mo ago −1.19%α −0.16% · $282.99
- T+20 · 8mo ago −7.08%α −2.10% · $266.12
- T+60 · 6mo ago −11.42%α −18.17% · $253.69
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
LH EVP Sandra van der Vaart sold $156K in open-market shares, part of a recent cluster of insider selling totaling $585K over the past 30 days. This represents a small fraction of the company's $23.6B market cap and aligns with routine, pre-planned trading activity.
Key Financial Metrics
Key Facts
- EVP Sandra van der Vaart sold 547.54 shares at $284.91, totaling $155,999.54 in open-market transaction
- This sale is part of a cluster of two insider sells in the last 30 days totaling $585K
- Total recent insider selling represents only 0.0025% of LH's $23.6B market cap
- No insider purchases reported in the last 7 or 30 days
Financial Impact
$156K in open-market sales by executive, $585K total insider selling in past 30 days
Risk Factors
- Potential perception of lack of confidence if selling continues ahead of earnings or key events
- Concentration of insider activity among senior executives, though volume remains low
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (1 trades, 7d window) | cluster-LH-1772552539055 |
Track record
29 reports on LH
5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +17.60% at T+60 after the Apr 30, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $372.32 Now $372.46 +0.04% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $372.23 Now $372.46 +0.06% settles Nov 18
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $363.30 to $372.32 Now $372.46 +2.52% ▲ +2.48% −0.81% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 4, 202612d ago 8-K Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $353.92 to $370.88 Now $372.46 +5.24% ▲ +4.79% +5.38% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $361.39 to $366.57 Now $372.46 +3.06% ▲ +1.43% +4.14% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $360.25 to $367.79 Now $372.46 +3.39% ▲ +2.09% +2.81% vs SPY
- Oct 26, 202621d ago Institutional Cluster Neutral 3/10 Entry $329.90 to $361.39 Now $372.46 +12.90% ▲ +9.55% +10.81% vs SPY
- Oct 21, 202626d ago 8-K Neutral 2/10 Entry $323.75 to $331.17 Now $372.46 +15.05% ▲ +2.29% +2.74% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers